tiprankstipranks
Trending News
More News >
BB Biotech AG (GB:0JYO)
LSE:0JYO
UK Market

BB Biotech (0JYO) Ratios

Compare
3 Followers

BB Biotech Ratios

GB:0JYO's free cash flow for Q4 2024 was CHF1.00. For the 2024 fiscal year, GB:0JYO's free cash flow was decreased by CHF and operating cash flow was CHF0.89. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
8.66 158.32 <0.01 <0.01 0.11
Quick Ratio
8.66 158.32 <0.01 <0.01 52.45
Cash Ratio
8.66 0.03 <0.01 <0.01 0.09
Solvency Ratio
4.19 -1.19 -1.83 -2.11 10.97
Operating Cash Flow Ratio
60.65 13.10 -0.97 -0.26 3.47
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
CHF -130.89MCHF 2.32BCHF -365.31MCHF -352.17MCHF -54.66M
Leverage Ratios
Debt-to-Assets Ratio
0.04 0.12 0.12 0.10 0.02
Debt-to-Equity Ratio
0.04 0.13 0.14 0.11 0.02
Debt-to-Capital Ratio
0.04 0.12 0.12 0.10 0.02
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.12 0.00 0.00
Financial Leverage Ratio
1.05 1.14 1.14 1.11 1.02
Debt Service Coverage Ratio
545.00 -34.70 -207.04 -408.58 782.76
Interest Coverage Ratio
545.05 -5.16 -206.27 -410.49 782.84
Debt to Market Cap
0.00 0.00 0.12 0.00 0.00
Interest Debt Per Share
2.73 5.67 6.63 6.43 1.15
Net Debt to EBITDA
0.18 -1.51 -1.01 -0.87 0.08
Profitability Margins
Gross Profit Margin
100.00%100.00%100.00%100.00%100.00%
EBIT Margin
99.22%100.58%101.37%101.90%99.25%
EBITDA Margin
98.87%100.85%101.73%101.66%98.86%
Operating Profit Margin
98.87%15.00%101.37%102.15%98.86%
Pretax Profit Margin
98.87%103.49%101.86%102.15%98.86%
Net Profit Margin
98.86%103.53%101.87%102.17%98.85%
Continuous Operations Profit Margin
98.86%103.53%101.87%102.17%98.85%
Net Income Per EBT
99.99%100.04%100.02%100.02%99.99%
EBT Per EBIT
100.00%690.08%100.48%100.00%100.00%
Return on Assets (ROA)
19.06%-7.83%-11.72%-11.11%17.44%
Return on Equity (ROE)
19.97%-8.89%-13.32%-12.33%17.78%
Return on Capital Employed (ROCE)
19.08%-1.14%-13.25%-12.33%17.78%
Return on Invested Capital (ROIC)
19.08%-0.57%-13.26%-12.33%17.78%
Return on Tangible Assets
19.06%-7.83%-11.72%-11.11%17.44%
Earnings Yield
18.46%-8.82%-11.78%-9.48%16.83%
Efficiency Ratios
Receivables Turnover
0.00 -109.11 0.00 0.00 0.00
Payables Turnover
0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.19 -0.08 -0.12 -0.11 0.18
Working Capital Turnover Ratio
29.57 -0.18 0.97 1.86 -34.88
Cash Conversion Cycle
0.00 -3.35 0.00 0.00 0.00
Days of Sales Outstanding
0.00 -3.35 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 0.00 0.00 0.00 0.00
Operating Cycle
0.00 -3.35 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
3.88 3.98 -6.50 -1.71 4.74
Free Cash Flow Per Share
3.88 3.98 -6.50 -1.71 4.74
CapEx Per Share
0.00 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
1.27 1.40 -1.69 -0.48 1.39
Capital Expenditure Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
1.43 0.72 -0.99 -0.27 4.17
Operating Cash Flow to Sales Ratio
0.31 -1.09 1.02 0.24 0.38
Free Cash Flow Yield
5.86%9.32%-11.78%-2.22%6.39%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
5.42 -11.34 -8.49 -10.55 5.94
Price-to-Sales (P/S) Ratio
5.36 -11.74 -8.65 -10.78 5.87
Price-to-Book (P/B) Ratio
1.08 1.01 1.13 1.30 1.06
Price-to-Free Cash Flow (P/FCF) Ratio
17.07 10.73 -8.49 -45.06 15.65
Price-to-Operating Cash Flow Ratio
17.07 10.73 -8.49 -45.06 15.65
Price-to-Earnings Growth (PEG) Ratio
-0.02 0.27 0.77 0.07 2.91
Price-to-Fair Value
1.08 1.01 1.13 1.30 1.06
Enterprise Value Multiple
5.59 -13.15 -9.51 -11.48 6.02
Enterprise Value
3.79B 2.65B 3.40B 4.62B 4.16B
EV to EBITDA
5.59 -13.15 -9.51 -11.48 6.02
EV to Sales
5.53 -13.26 -9.67 -11.67 5.95
EV to Free Cash Flow
17.62 12.13 -9.50 -48.78 15.86
EV to Operating Cash Flow
17.62 12.13 -9.50 -48.78 15.86
Tangible Book Value Per Share
61.24 42.39 48.83 59.41 70.41
Shareholders’ Equity Per Share
61.24 42.39 48.83 59.31 70.18
Tax and Other Ratios
Effective Tax Rate
<0.01 >-0.01 >-0.01 >-0.01 <0.01
Revenue Per Share
12.37 -3.64 -6.38 -7.16 12.62
Net Income Per Share
12.23 -3.77 -6.50 -7.31 12.48
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.00 1.03 1.00 1.00 1.00
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
<0.01 -0.02 -0.01 -0.02 <0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.32 -1.06 1.00 0.23 0.38
Currency in CHF
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis